PDF(Pubmed)
Abstract：
Background: Heart failure (HF) affects around 60 million individuals worldwide. The primary aim of this study was to evaluate the efficacy of lung ultrasound (LUS) in managing HF with the goal of reducing hospital readmission rates. Methods: A systematic search was conducted on PubMed, Embase, Google Scholar, Web of Science, and Scopus, covering clinical trials, meta-analyses, systematic reviews, and original articles published between 1 January 2019 and 31 December 2023, focusing on LUS for HF assessment in out-patient settings. There is a potential for bias as the effectiveness of interventions may vary depending on the individuals administering them. Results: The PRISMA method synthesized the findings. Out of 873 articles identified, 33 were selected: 19 articles focused on prognostic assessment of HF, 11 centred on multimodal diagnostic assessments, and two addressed therapeutic guidance for HF diagnosis. LUS demonstrates advantages in detecting subclinical congestion, which holds prognostic significance for readmission and mortality during out-patient follow-up post-hospital-discharge, especially in complex scenarios, but there is a lack of standardization. Conclusions: there are considerable uncertainties in their interpretation and monitoring changes. The need for an updated international consensus on the use of LUS seems obvious.
摘要：
背景：心力衰竭（HF）影响全球约6000万人。这项研究的主要目的是评估肺部超声（LUS）在治疗HF中的功效，以降低住院再入院率。方法：在PubMed上进行系统搜索，Embase,谷歌学者，WebofScience,还有Scopus,涵盖临床试验，荟萃分析，系统评价,以及在2019年1月1日至2023年12月31日期间发表的原创文章，重点是LUS用于门诊心力衰竭评估。由于干预措施的有效性可能因个人的不同而有所不同，因此存在偏见的可能性。结果：PRISMA方法综合了研究结果。在确定的873篇文章中，共入选33篇：19篇重点关注HF的预后评估，11以多模式诊断评估为中心，和两个解决HF诊断的治疗指导。LUS在检测亚临床充血方面表现出优势，这对出院后门诊随访期间的再入院和死亡率具有预后意义，尤其是在复杂的场景中，但缺乏标准化。结论：它们的解释和监测变化存在相当大的不确定性。关于使用LUS的最新国际共识的必要性似乎显而易见。
